Dr Amanda Leach presents ‘Pneumococcal antibody responses in Tiwi infants: Part 1’, on Monday 8 October from 12pm to 1pm.
Australian Aboriginal infants are at high risk of invasive pneumococcal disease (IPD), otitis media and carriage. The 7-valent pneumococcal conjugate vaccine (7PCV) was estimated to cover 60 per cent of invasive serotypes. A schedule of 7PCV at two, four and six months, and 23-valent polysaccharide vaccine (23PPV) at 18 months of age was introduced for Indigenous infants in 2001.
Serum IgG to sixteen serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 12F, 14, 15, 18C, 19A, 19F, 23F and 33F) was measured at birth, one month following the primary three dose 7PCV course, and pre- and post- 23PPV booster dose.
In her presentation, Dr Leach will report on comparisons with controls and with published studies.
Dr Leach is with the Microbiology - Ear and Respiratory Infections division at the Menzies School of Health Research.
This seminar takes place in the Menzies Seminar Room, John Mathews Building, Royal Darwin Hospital Campus.
Visit the Menzies School of Health Research website for information about this and future seminars.